http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107115334-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93a15a952398dc822e4f253ffdb9c8bd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
| filingDate | 2017-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30669958604c50b05a0ef1ee67fd7d53 |
| publicationDate | 2017-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107115334-A |
| titleOfInvention | A kind of pharmaceutical composition for treating immune abortion |
| abstract | The invention discloses a pharmaceutical composition for treating immune abortion. The pharmaceutical composition is composed of a certain amount of active pharmaceutical ingredients, commonly used pharmaceutical carriers and auxiliary materials, wherein the structure of the effective pharmaceutical ingredients is: Wherein R1 is independently selected from: H, alkyl or halogen; from the perspective of therapeutic effect, the pharmaceutical composition for treating immune abortion according to the present invention has the effect of anti-immune spontaneous abortion, and can reduce spontaneous abortion in pregnant women after using the medicine. The possibility of miscarriage is a relatively satisfactory drug for the treatment of immune miscarriage. From the point of view of the mechanism of action, the medicine of the present invention has the advantages of strong specificity and high sensitivity for the treatment and prevention of autoimmune abortion. |
| priorityDate | 2017-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.